Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT03634904
Eligibility Criteria:
Inclusion Criteria:
* any patient with 18 years of age or older and chronically treated by hemodialysis in the hemodialysis ward of the Institution, and
* for whom ceftazidime is administered for treating a suspected or confirmed infection for which ceftazidime is indicated, and
* who has given her/his informed consent.
Exclusion Criteria:
* patient with suspected or confirmed allergy to beta-lactam antibiotics
* pregnant women (based on patient's declaration)
* nursing women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03634904
Study Brief:
Protocol Section:
NCT03634904